-
Product Insights
PulteGroup – Parkside at Finch Creek Residential Community – Indiana
Equip yourself with the essential tools needed to make informed and profitable decisions with our PulteGroup - Parkside at Finch Creek Residential Community - Indiana report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Clostridioides Difficile Infections (Clostridium Difficile Associated Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Clostridioides difficile Infections – Drugs In Development, 2022, provides an overview of the Clostridioides difficile Infections (Infectious Disease) pipeline landscape. Clostridium difficile infections are caused by Clostridium difficile, often called C. difficile or C. diff, a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. Symptoms of C. diff infection includes watery diarrhea, with abdominal pain or tenderness, loss of appetite, fever, blood or pus...
-
Thematic Analysis
Microbiome-Targeting Therapeutics in Infectious Diseases – Thematic Research
Microbiome is the community of microorganisms such as fungi, bacteria, and viruses, and their genetic material existing in and on the human body. Although the primary site of aggregated microbes is in the gastrointestinal (GI) tract, populations of microorganisms are also found on the surface of the skin, in the upper and lower respiratory tract, and in the genitourinary tracts. Microbiome-targeting drugs aim to alter the microbial composition of the gut through the administration of live microbes (probiotics), or other...
-
Product Insights
Clostridioides difficile Infections (Clostridium difficile Associated Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Clostridioides difficile Infections Clinical Trial Analysis research report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report also provides prominent drugs for in-progress trials.
-
Product Insights
Crohn’s Disease (Regional Enteritis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Crohn’s Disease (Regional Enteritis) pipeline market research report provides comprehensive information on the therapeutics under development for Crohn's Disease (Regional Enteritis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Crohn's Disease...
-
Product Insights
Autism – Global Clinical Trials Review, 2022
The autism clinical trial market research report provides an overview and top-line data relating to the clinical trials on autism. The report includes an overview of trial counts and their average enrollment in top countries conducted globally. It also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on the number of ongoing trials).
-
Company Insights
Airbnb Inc. – Enterprise Tech Ecosystem Series
Founded in 2008, Airbnb, Inc. (Airbnb) operates an online marketplace offering hospitality services. The company’s mobile application (app) enables users to list, discover, and book accommodations across the world, offering unique travel experiences, at any price point, in more than 220+ countries and regions. The app allows hosts to list their properties and enables guests to rent or lease the same for short- or long-term stays. The properties listed for accommodation include vacation rentals, apartment rentals, homestays, castles, treehouses or...
-
Product Insights
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Clostridium difficile Infections (Clostridium difficile Associated Disease) Global Clinical Trials Review, H1, 2019" provides an overview of Clostridium difficile Infections (Clostridium difficile Associated Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Clostridium difficile Infections (Clostridium difficile Associated Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Company Insights
Enterprise Tech Ecosystem Series – Airbnb, Inc.
Airbnb, Inc. (Airbnb) operates an online marketplace offering hospitality services. The company’s flagship mobile application (app) enables users to list, discover, and book unique accommodations across the world, offering unique travel experiences, at any price point, in more than 33,000 cities and 191 countries.